Tagged with M

Leo Pharma Austria You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the head of the affiliate? 2012 has overall been an interesting year, as LEO Pharma stepped into new fields of indication…

Baker & Mckenzie Mexico The regulatory framework in Mexico is in constant change, and pharmaceutical com-panies are struggling to comply. What sort of challenges are companies facing when deal-ing with COFEPRIS and what must be achieved? Permanent legal uncertainty and lack of transparency are the main challenges to re-solve. The first step would be…

Merck Sharp & Dohme Austria You have been the head of MSD’s Austrian operations since April 2009. Can you start by telling our readers about the evolution of the affiliate since the merger with Schering Plough? I have been with MSD Austria since before the merger, I started in early 2009 when the merger had…

Bio-Rad Mexico Bio-Rad products are used in hospitals, universities, major research institutions, biotechnology companies, reference laboratories, pharmaceutical firms… How is Bio-Rad Mexico positioned with its products in the country? Based on the dedication and excellent work the Mexican Team did for several years, in the clinical diagnostics market, Bio-Rad is immediately linked…

Medtronic México Medtronic is the global leader in medical technology. The company has 2 manufacturing facilities in Mexico and the Mexican subsidiary was officially set up in 1970, but could you give us a brief rundown of Medtronic Mexico’s current activities within the global operations? Medtronic was founded in 1949 in a…

KaVo Sybron-Dental México We have seen that the company has been through a series of mergers and acquisitions. Could you give us a rundown of the company’s transitions? We are currently building a subsidiary of a corporation named Danaher, which is a US based public company. In recent years, Danaher redefined its investment…

Boehringer Ingelheim Singapore What is the presence of Boehringer Ingelheim (BI) in Southeast Asia? In 2009, Boehringer Ingelheim decided to establish a regional operating unit for its human pharmaceutical division (prescription and OTC products) in Southeast Asia that would be managed from Singapore. This business unit was designated to oversee of all the…

ASLAN pharmaceuticals Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into pharmaceutical R&D working for AstraZeneca. After five or so years I was very keen to get commercial exposure, to see how we actually access…

Takeda Global Research & Development Center (Asia) What is the global R&D vision of Takeda, Japan’s largest pharmaceutical company that recently celebrated its 230th birthday? Takeda’s global R&D vision is committed to the discovery and development of innovative solutions that addresses unmet medical needs of patients. What distinguishes our R&D vision is an emphasis on innovation and…

Alandra Medical México Before we get into the company’s activities and market, could you give us a brief rundown of your past working experience prior to Alandra Medical? My experience outside of the United States is extensive, since I had been work-ing for Intel Corp. for more than twenty years and lived in…

Boehringer Ingelheim Austria Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first foreign subsidiary in 1948. Can you give our readers a snapshot of the strategic importance Austria has today for the…

Teva Ratiopharm Austria Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed directions in its development, determined to be a multifaceted company, offering to the market not only generics but also branded…